Your browser doesn't support javascript.
loading
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1.
Armstrong, Amy E; Rhodes, Steven D; Smith, Abbi; Chen, Shi; Bessler, Waylan; Ferguson, Michael J; Jiang, Li; Li, Xiaohong; Yuan, Jin; Yang, Xianlin; Yang, Feng-Chun; Robertson, Kent A; Ingram, David A; Blakeley, Jaishri O; Clapp, D Wade.
Afiliación
  • Armstrong AE; Division of Pediatric Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana.
  • Rhodes SD; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Smith A; Present address: Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Chen S; Division of Pediatric Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana.
  • Bessler W; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Ferguson MJ; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Jiang L; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Li X; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Yuan J; Division of Pediatric Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana.
  • Yang X; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Yang FC; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Robertson KA; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Ingram DA; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Blakeley JO; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
  • Clapp DW; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indianapolis, Indiana.
Pediatr Blood Cancer ; 67(8): e28372, 2020 08.
Article en En | MEDLINE | ID: mdl-32459399
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neurofibromatosis 1 / Neurofibroma Plexiforme / Mesilato de Imatinib / Neoplasias Experimentales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neurofibromatosis 1 / Neurofibroma Plexiforme / Mesilato de Imatinib / Neoplasias Experimentales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2020 Tipo del documento: Article